Hardik Onco Care
Ambawadi, Ahmedabad, Gujarat
GST No. 24AAIFH1852R1ZY
TrustSEAL Verified
Call 08048745728100% Response Rate
SEND EMAIL
We are a leading wholesaler, trader and supplier of a wide range of Biomab
BIOMAB
BIOMAB 200MG
BIOMAB NIMOTUZUMAB
NIMOTUZUMAB 200MG
NIMOTUZUMAB 50MG
Product Details:
| Brand | biomab |
| Packaging Type | vial |
| Composition | nimotuzumab |
| Drug Name | nimotuzumab |
| Packaging Size | 4*50mg |
| Dose | 200mg |
| Certification | FDA |
| Dosage Form | 200mg |
| Form of Medicine | vial |
Biomab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR). Clinical trials are ongoing globally to evaluate it in different indications. Ithas been granted approval for use in squamous cell carcinoma of head and neck (SCCHN), glioma and nasopharyngeal cancer.
Available As: 4X10 ml
Product Details:
| Brand | Biomab |
| Composition | nimotuzumab |
| Drug Name | nimotuzumab |
| Dose | 200mg |
| Certification | FDA |
With an extensive experience in the industry, we source and offer a Biomab . Owing to the purity, effectiveness and accurate composition, these are widely used in treating major diseases. Our range is processed using fine quality ingredients, which can be availed at industry-leading prices.
Other Information
Pay Mode Terms: L/C (Letter of Credit), D/A (Documents Against Acceptance), D/P (Documents Against Payment), T/T (Bank Transfer), Western Union, others
Product Details:
| Brand | BIOMAB |
| Composition | Nivolumab,Nimotuzumab |
| Drug Name | Nimotuzumab |
| Dose/Strength | Nimotuzumab |
Biomab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR). Clinical trials are ongoing globally to evaluate it in different indications. It has been granted approval for use in squamous cell carcinoma of head and neck (SCCHN), glioma and nasopharyngeal cancer.
Available As: 4X10 ml
Additional Information:
Product Details:
| Usage/Application | cancer |
| Composition | nimotuzumab |
| Drug Name | nimotuzumab |
| Salt | nimotuzumab |
| Dose/Strength | 200mg |
| Dosage Form | injection |
| Form of Medicine | vial |
| Storage Condition | cool chain |
| Brand | Biomab |
Biomab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR). Clinical trials are ongoing globally to evaluate it in different indications. It has been granted approval for use in squamous cell carcinoma of head and neck (SCCHN), glioma and nasopharyngeal cancer.